Press "Enter" to skip to content

FDA approves cheaper Botox rival to treat frown lines

An injection to treat forehead wrinkles is set to rival Allergan’s Botox after U.S. regulators approved Evolus Inc’s cheaper treatment on Friday, sending its shares up about 5 percent after the bell.

Also Read:   U.S. rushes to build makeshift hospitals as death toll rises over 800